Evaluation of amiloride combined with hydrochlorothiazide (Moduretic) in the treatment of hypertension.
D000328:Adult; D000368:Aged; D000584:Amiloride / Q000009:adverse effects / Q000627:therapeutic use; D001581:Benzothiadiazines / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects / Q000627:therapeutic use*; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011433:Propranolol / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use*; D014508:Urea / Q000097:blood; D014511:Uremia / Q000188:drug therapy
D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D011719:Pyrazines; D006852:Hydrochlorothiazide; D008750:Methyldopa; D000584:Amiloride; D014508:Urea; D011433:Propranolol; D011188:Potassium; D006145:Guanethidine